跳至主要內容

臺北市資料大平臺

:::

Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
員工報告

檔案下載

資料項目檔案大小檔案格式更新時間操作

詮釋資料

計畫摘要 "BACKGROUND: Headaches resulting from proton pump inhibitor (PPI) use could cause discontinuation of PPI in as many as 40% of patients who experience such headaches. Previous studies focusing on acute headache risk from PPI use are rare and limited to clinical trials of a single PPI. OBJECTIVES: To investigate the association between PPI use and headache with a nationwide population-based case-crossover study. METHODS: Records containing the first diagnosis of any headache, including migraine and tension-type headaches, were retrieved from Taiwan National Health Insurance Database (1998-2010). We compared the rates of PPI use for cases and controls during time windows of 7, 14, and 28 days. The adjusted self-matched odds ratios (ORs) and 95% confidence intervals (CIs) from a conditional logistic regression model were used to determine the association between PPI use and headache. RESULTS: Overall, 314,210 patients with an initial diagnosis of any headache during the study period were enrolled. The adjusted ORs for headache risk after PPI exposure were calculated for three time periods (within 7 days=1.41, p=0.002, 95% CI 1.14-1.74; within 14 days=1.36, p<0.001, 95% CI 1.16-1.59; within 28 days=1.20, p=0.002, 95% CI 1.07-1.35). Subgroup analyses showed female patients had an increased risk of headache. Among PPIs, lansoprazole and esomeprazole had the highest risks of headache incidence, which were similar to that of nitrates. CONCLUSION: PPI usage is associated with an increased risk for acute headache. Female patients and use of lansoprazole or esomeprazole present the greatest risks of headache."
資料集研究(主辦)機關 衛生局聯合醫院
年度 104
研究人員 Liang JF, Chen YT(陳永泰), Fuh JL, Li SY, Chen TJ, Tang CH, Wang SJ
關鍵詞 期刊
備註 本專區110年以前為歷史轉檔資料,因新舊平臺欄位規格不同,故有部分詮釋資料欄位無資訊;如對資料內容有疑義,請洽資料集主辦機關或本府研考會研究發展組。